NCT04161976 A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT04159701 A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria Status TERMINATED Phase PHASE2
NCT04158752 Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia Status COMPLETED Phase PHASE4
NCT04158700 A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT04157751 A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure Status COMPLETED Phase PHASE3
NCT04153981 A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India Status COMPLETED Phase PHASE4
NCT04152382 A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis Status TERMINATED Phase PHASE1
NCT04151563 A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy Status WITHDRAWN Phase PHASE1/PHASE2
NCT04148937 A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT04146363 Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) Status COMPLETED Phase PHASE3
NCT04145700 CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma Status TERMINATED Phase PHASE1/PHASE2
NCT04145349 CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor Status COMPLETED Phase PHASE1/PHASE2
NCT04143802 A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT04127578 Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04106362 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma Status TERMINATED Phase PHASE2
NCT04106219 A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1